1. Nosal’ova V, Drabikova K, Zurova-Nedelcevova J,
Jancinova V, Okruhlicova L, Nosal R, Sotnikova R.
Ischaemia/reperfusion-induced organ injury in low
dose streptozotosin diabetes. Neuro Endocrinol Lett
2006; 2: 152-155.
2. Salas A, Panes J, Rosenbloom CL, Elizalde JI,
Anderson DC, Granger DN, Pique JM. Differential
effects of a nitric oxide donor on reperfusion-induced
microvascular dysfunction in diabetic and non-diabetic
rats. Diabetologia 1999; 42: 1350-1358.
3. Suzuki O, Matsubara T, Kanashiro M, Nakao 0,
Terada J, Nishimura H, Haruta K, Ikeda T, Sakamoto
N. Are diabetic hearts more resistant to ischemia/
reperfusion injury? Jpn Circ J 1993; 57: 328-334.
4. Nawata T, Takahashi N, Ooie T, Kaneda K, Saikawa
T, Sakata T. Cardioprotection by Streptozotocininduced
diabetes and insulin against ischemia/reperfusion
injury in rats. J Cardiovasc Pharmacol 2002;
40: 491-500.
5. Korthuis RJ, Smith JK, Carden DL. Hypoxic reperfusion
attenuates postischemic microvascular injury.
Am J Physiol 1989; 256: 315-319.
6. Pape D, Beuchard J, Guillo P, Allain H, Bellissant E.
Hypoxic Contractile Response in ‹solated Rat
Thoracic Aorta: Role of Endothelium, Extracellular
Calcium and Endothelin. Fundam Clin Pharmacol
1997; 11: 121-126.
7. Gao H, Korthuis RJ, Benoit JN. Effects of
Hypoxia/Reoxygenation on Aortic Vasoconstrictor
Responsiveness. Free Radic Biol Med 1996; 21: 591-
600.
8. Lebovitz, H.E. Etiology and Pathogenesis Diabetes
Mellitus. Pediatrics Clinics of North America 1984;
31: 521-530.
9. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis:
epidemiology, pathophysiology, and
management. JAMA 2002; 287: 2570-2581.
10. Hu FB, Stampfer MJ, Solomon CG, et al. The impact
of diabetes mellitus on mortality from all causes and
coronary heart disease in women: 20 years of followup.
Arch Intern Med 2001; 161: 1717-1723.
11. Tesfamariam P, Halpern W. Endothelium Dependent
and Endothelium ‹ndependent Vasodilation in
Resistance Arteries from Hypertensive Rats.
Hypertension 1988; 11: 440-444.
143
Cerrahpafla T›p Derg 2008; 39(4): 136-143
12. Dohi Y, Thiel M.A. Activation of the Endothelial LArginin
Pathway in Pressurized Mesenteric Resistance
Arteries: Effect of Age and Hypertension.
Hypertension 1990; 15: 170-179.
13. Moncadad S, Higgs E.A. Molecular Mechanism and
Therapeutic Strategies Related to NO. Faseb J 1995;
9: 1319-1330.
14. Panza J.A, Brush J.E. Abnormal Endothelium
Relaxation in Patients with Essential Hypertension. N
Eng J Med 1990; 323: 22-27.
15. Cooke J.P, Andon N.A. Arginine Restores Cholinergic
Relaxation of hypercholesterolemic Rabbit Aorta.
Circulation 1991; 83: 1057-1062.
16. Lopez-Virella M.F, Virella G. Immune Mechanism of
Atherosclerosis in Diabetes Mellitus. Diabetes 1992;
41: 86-91.
17. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, et al.
Ischemia/reperfusion injury. J Surg Res 2002; 105:
248-258.
18. Macleod KM. Effect of Insulin Treatment on Changes
in Vascular Reactivity in Chronic Experimental
Diabetes. Diabetes 1985; 34: 1160-1167.
19. Piper G.M. Review of Alterations in Endothelial Nitric
Oxide Production in Diabetes. Protective Role
Arginine on Endothelial Dysfunction. Hypertension
1998; 31: 1047-1060.
20. Karasu Ç, Altan V.M. The Role of Endothelial Cells on
Alterations in Vascular Reactivity Induced by Insulin
Dependent Diabetes Mellitus: Effect of Insulin
Treatment. Gen Pharmacol 1993; 24: 743-755.
21. Karasu Ç, Ozansoy G, Bozkurt O, Erdo¤an G,
Ömero¤lu S. Antioxidant and Triglyceride Lowering
Effects of Vitamine E Associated with the Prevention
of Abnormalities in the Reactivity and Morphology of
Aorta from STZ Diabetic Rats. Metabolism 1997; 46:
872-879.
22. Taylor PD, Oon B.B, Thomas C.R, Poston L.
Prevention by Insulin Treatment of Endothelial
Dysfunction but not Enhanced Noradrenaline
‹nduced Contractility in Mesenteric Resistance
Arteries from STZ-Induced Diabetic Rats. Br J
Pharmacol 1994; 111: 35-41.
23. Pfaffman M.A, Hilman R, Darby A. Contractilite and
Relaxing Activity of Arterial Smooth Muscle from
STZ-Diabetic Rats. Res Commun Chem Pathol
Pharmacol 1980; 30: 283-299.
24. Ramanadham S, Lynes W.H, Tenner T.E. Alterations
in Aortic and Tail Artery Reactivity to Agonists After
STZ. Treatment. Can J Physiol Pharmacol 1984; 62:
418-423.
25. Head R.J, Longhurst P.A, Panek R.L, Stitzel R.E. A
Contrasting Effect of the Diabetic State up on the
Contractile Responses of Aortic Preperation from the
Rat and Rabbit. Br J Pharmacol 1987; 91: 275-286.
26. Takiguchi Y, Satoh N, Hashimoto H, Nakashima M.
Reserval Effects of Thyroxine on Altered Vascular
Reactivity in Diabetic Rats. J Cardiovasc Pharmacol
1989; 13: 520-524.
27. Sikorski B.W, Hodgson W.C, King R.G. Effects of
Hemoglobin and N-Nitro-L-Arginine on constrictor
and Dilator Responses of Aortic Rings from STZDiabetic
Rats. Eur J Pharmacol 1994; 242: 275-282.
28. Owen M.P, Carrier G.O. Alteration in Vascular
Smooth Muscle Sensitivity to Vasoconstrictor Agents
by STZ-İnduced Diabetic Diabetes. Proct West
Pharmacol Soc 1979; 22: 363-366.
29. Fortes Z.B, Garcia L.C, Scivoletto R.Vascular
Reactivitiy in Diabetes Mellitus: Role of Endothelial
Cells. Br J Pharmacol 1983; 79: 771-781.
30. Ramos O.L. Diabetes Mellitus and Hypertension:
State of Art. Lecture 1988; 11: 114-118.
31. Mulhern M, Docherty J. Effects of Experimentals
Diabetes on Responsiveness of Rat Aorta. Br J
Pharmacol 1989; 97: 1007-1012.
32. Abiru T, Kamata K. Effects of Diabetes on Vascular
Responses of Basillary Artery and Aorta from Rabbits
with Alloxan-‹nduced Diabetes. Res. Commun. Chem
Pathol Pharmacol 1991; 74: 71-87.
33. Fulton D.J.R, Hodgson W.C. Attenuated Responses to
Endothelin–1 KCL and CaCl2 but not Noradrenaline
of Aorta from Rats with STZ-induced Diabetes
Mellitus. Br J Pharmacol 1991; 104: 928-932.
Thank you for copying data from http://www.arastirmax.com
